Latest Breaking News On - Specialty therapeutics - Page 1 : comparemela.com

Innovative Treatment for Gonorrhea: Phase III Trial Shows Promise for Zoliflodacin

Phase III trial of zoliflodacin shows it as effective as current treatments for uncomplicated gonorrhea, highlighting its potential in combating rising antibiotic resistance.

Comunidad autonoma de catalunaMatt ronsheimAlison luckeyEuropean society of clinical microbiologyWorld health organizationAdobe stockEuropean societyClinical microbiologyInfectious diseasesInfection control todayInnoviva specialtySpecialty therapeuticsInnoviva specialty therapeutics

Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China

Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on.

Hong kongNew zealandRepublic ofUnited statesHarald reinhartMatt ronsheimAcinetobacter baumanniiCenters for diseaseHead of global developmentZai lab limitedZai labSecurities exchangeInnoviva incDrug administrationZai lab forwardExchange commission

Innoviva Specialty Therapeutics Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024

Innoviva Specialty Therapeutics Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South africaComunidad autonoma de catalunaUnited kingdomSarah mcleodDavid pattiAlison luckeyDennis riedlGabrielle kornmanDavid altaracHealth emergency preparednessGlobal antibiotic research development partnershipInnoviva incFoundation in genevaUs centers for diseaseInnoviva specialty therapeutics incInfectious disease global congress

Innoviva and GARDP reveal positive results for antibiotic to treat gonorrhoea

Innoviva and GARDP reveal positive results for antibiotic to treat gonorrhoea
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

South africaPavel raifeldManica balasegaramGlobal antibiotic researchDevelopment partnershipSpecialty therapeutics

Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to T

A Phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone and oral azithromycin, a current international standard of care.Positive top-line study results are a significant milestone in the development of a first-in-class antibiotic against drug-resi.

South africaUnited kingdomUnited statesGrand duchy of luxembourgManica balasegaramDavid pattiPavel raifeldGlobal antibiotic research development partnershipLeo model foundationCorporate communicationsAfrican medical research councilUs national institute of allergyEntasis therapeutics incPublic health agency of canadaDrug administrationWorld health organization